Melanoma complicating treatment with Natalizumab (Tysabri) for multiple sclerosis-Reference-Cited by-同舟云学术

Melanoma complicating treatment with Natalizumab (Tysabri) for multiple sclerosis

Published:2009-07-16 Issue:10 Volume:256 Page:1771-1772
ISSN:0340-5354
Container-title:Journal of Neurology
language:en
Short-container-title:J Neurol

Author:

Ismail Azza,Kemp Julie,Sharrack Basil

Publisher

Springer Science and Business Media LLC

Subject

Clinical Neurology,Neurology

Link

http://link.springer.com/content/pdf/10.1007/s00415-009-5200-9.pdf

Reference15 articles.

1. Adelman B, Sandrock A, Panzara MA (2005) Natalizumab and progressive multifocal leukoencephalopathy. N Engl J Med 353:432–433

2. Bauer R, Humphries M, Fassler R, Winklmeier A, Craig SE, Bossehoff AK (2006) Regulation of integrin activity by MIA. J Biol Chem 281:11669–11677

3. Davenpor RJ, Munday JR (2007) Alpha4-integrin antagonism—an effective approach for the treatment of inflammatory diseases? Drug Discov Today 12(13-14):569

4. http://investor.biogenidec.com/phoenix.zhtml?c=148682&p=irol-TPME . Accessed 29 April 2009

5. Kedl RM, Mescher MF (1997) Migration and activation of antigen-specific CD8+ T cells upon in vivo stimulation with allogeneic tumour. J Immunol 159:650–663

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer and multiple sclerosis: 2023 recommendations from the French Multiple Sclerosis Society;Multiple Sclerosis Journal;2024-02-15

2. Multiple sclerosis and melanoma;Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova;2023

3. Safety of Newer Disease Modifying Therapies in Multiple Sclerosis;Vaccines;2020-12-26

4. Multiple Sclerosis Treatment and Melanoma Development;International Journal of Molecular Sciences;2020-04-22

5. Cancers and multiple sclerosis: risk of comorbidity and influence of disease modifying therapy;Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova;2019